Prediction Models for Elevated Cardiac Biomarkers from Previous Risk Factors and During the COVID-19 Pandemic in

Joao Caballero-Vidal1, Jorge Luis Díaz-Ortega1,2, Irma Luz Yupari-Azabache2

  • 1Escuela Profesional de Nutrición, Universidad César Vallejo, Trujillo 13001, Peru.

PubMed

Insights

Repeated COVID-19 infections correlate with elevated cardiac troponin inhibitor (cTnI) levels. Cardiovascular risk factors, like comorbidities and LDL, are linked to NT-proBNP, indicating potential cardiac damage prevention strategies.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Cardiac troponin (cTnI) indicates myocardial injury, while NT-proBNP signifies myocardial insufficiency.
  • Understanding associations between cardiovascular risk factors, SARS-CoV-2 infection history, and these biomarkers is crucial for cardiac health.
  • High prevalence of cardiovascular risk factors was noted in the study population.

Purpose of the Study:

  • To develop binary logistic regression models to assess the association of cardiovascular risk indicators, pre-pandemic history, SARS-CoV-2 infection frequency, and vaccination status with cTnI and NT-proBNP levels.
  • To identify predictors of elevated cardiac biomarkers in a Peruvian urban population.

Main Methods:

  • A cross-sectional study involving 281 residents of Trujillo, Peru, from September to December 2023.
  • Data collection included cardiovascular risk factors (obesity, glycemia, lipid profile), SARS-CoV-2 infection history, vaccination status, and serum concentrations of cTnI and NT-proBNP.
  • Binary logistic regression analysis was employed to determine associations.

Main Results:

  • High prevalence of abdominal obesity (55.2%), elevated glycemia (53%), hypercholesterolemia (49.8%), low HDL (71.9%), and high LDL (78.6%) were observed.
  • A significant association was found between the number of SARS-CoV-2 infections and elevated cTnI levels (OR = 3.513, p = 0.003).
  • The number of comorbidities (OR = 2.185, p = 0.025) and LDL levels (OR = 0.209, p = 0.025) were associated with NT-proBNP levels.

Conclusions:

  • Increased SARS-CoV-2 infection frequency is linked to higher cTnI levels, suggesting a potential for myocardial injury.
  • Comorbidities and LDL cholesterol levels are associated with NT-proBNP, highlighting their role in myocardial insufficiency.
  • These findings contribute to understanding and preventing cardiac damage in the context of cardiovascular risk and viral infections.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Pericarditis II: Clinical features and Diagnostic Tests01:19

Pericarditis II: Clinical features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
3